Literature DB >> 22207207

Optimizing adenoviral transduction of endothelial cells under flow conditions.

Martina Anton1, Anja Wolf, Olga Mykhaylyk, Christian Koch, Bernd Gansbacher, Christian Plank.   

Abstract

PURPOSE: To target adenoviral vectors to cells of the vasculature and shielding vectors from inactivation by the immune system.
METHODS: Complexes of reporter gene expressing adenoviral vectors with positively charged magnetic nanoparticles were formed by electrostatic interaction in presence or absence of additional negatively charged poly(ethylene glycol)-based polymer. Transduction of HUVEC was analyzed in vitro under flow. Protection from inactivation by the immune system was analyzed by pre-incubation of AdV and complexes with neutralizing antibodies and subsequent reporter protein analysis of infected cells.
RESULTS: Physical association of AdV with MNP and polymers was demonstrated by radioactive labelling of components and co-sedimentation in a magnetic field. Ad-MNP+/-polymer resulted in efficient transduction of HUVEC, depending on MOI and flow rate in presence of magnetic field, whereas no transduction was observed without complex formation with MNP or in absence of magnetic field. Association with MNP did result in protection from neutralizing antibodies, with slightly increased protection provided by the polymer.
CONCLUSIONS: Complex formation of AdV with MNP is a viable means for targeting of vectors to areas of magnetic field gradient. Additional coating with polymer might proof useful in protection from inactivation by the immune system.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22207207     DOI: 10.1007/s11095-011-0631-2

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  47 in total

1.  In vitro and in vivo characterisation of endothelial cell selective adenoviral vectors.

Authors:  Stuart A Nicklin; Steve J White; Campbell G Nicol; Dan J Von Seggern; Andrew H Baker
Journal:  J Gene Med       Date:  2004-03       Impact factor: 4.565

2.  Adenoviral gene vector tethering to nanoparticle surfaces results in receptor-independent cell entry and increased transgene expression.

Authors:  Michael Chorny; Ilia Fishbein; Ivan S Alferiev; Origene Nyanguile; Richard Gaster; Robert J Levy
Journal:  Mol Ther       Date:  2006-06-27       Impact factor: 11.454

Review 3.  siRNA delivery by magnetofection.

Authors:  Olga Mykhaylyk; Olivier Zelphati; Joseph Rosenecker; Christian Plank
Journal:  Curr Opin Mol Ther       Date:  2008-10

4.  Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generate an endothelial cell-selective adenovirus.

Authors:  S A Nicklin; D J Von Seggern; L M Work; D C Pek; A F Dominiczak; G R Nemerow; A H Baker
Journal:  Mol Ther       Date:  2001-12       Impact factor: 11.454

5.  Magselectofection: an integrated method of nanomagnetic separation and genetic modification of target cells.

Authors:  Yolanda Sanchez-Antequera; Olga Mykhaylyk; Niek P van Til; Arzu Cengizeroglu; J Henk de Jong; Marshall W Huston; Martina Anton; Ian C D Johnston; Zygmunt Pojda; Gerard Wagemaker; Christian Plank
Journal:  Blood       Date:  2011-02-28       Impact factor: 22.113

6.  Silica-iron oxide magnetic nanoparticles modified for gene delivery: a search for optimum and quantitative criteria.

Authors:  Olga Mykhaylyk; Titus Sobisch; Isabella Almstätter; Yolanda Sanchez-Antequera; Sabine Brandt; Martina Anton; Markus Döblinger; Dietmar Eberbeck; Marcus Settles; Rickmer Braren; Dietmar Lerche; Christian Plank
Journal:  Pharm Res       Date:  2012-01-06       Impact factor: 4.200

7.  Efficient infection of tumor endothelial cells by a capsid-modified adenovirus.

Authors:  K Shinozaki; E Suominen; F Carrick; B Sauter; V-M Kähäri; A Lieber; S L C Woo; M Savontaus
Journal:  Gene Ther       Date:  2006-01       Impact factor: 5.250

8.  A novel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo.

Authors:  Ken-ichi Ogawara; Marianne G Rots; Robbert J Kok; Henk E Moorlag; Anne-Miek Van Loenen; Dirk K F Meijer; Hidde J Haisma; Grietje Molema
Journal:  Hum Gene Ther       Date:  2004-05       Impact factor: 5.695

Review 9.  Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide.

Authors:  Florian Kreppel; Stefan Kochanek
Journal:  Mol Ther       Date:  2007-10-02       Impact factor: 11.454

10.  Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1.

Authors:  Robert C Carlisle; Ying Di; Anna M Cerny; Andreas F-P Sonnen; Robert B Sim; Nicola K Green; Vladimir Subr; Karel Ulbrich; Robert J C Gilbert; Kerry D Fisher; Robert W Finberg; Leonard W Seymour
Journal:  Blood       Date:  2009-01-08       Impact factor: 22.113

View more
  3 in total

1.  Optimization of magnetic nanoparticle-assisted lentiviral gene transfer.

Authors:  Christina Trueck; Katrin Zimmermann; Olga Mykhaylyk; Martina Anton; Sarah Vosen; Daniela Wenzel; Bernd K Fleischmann; Alexander Pfeifer
Journal:  Pharm Res       Date:  2012-01-25       Impact factor: 4.200

2.  Silica-iron oxide magnetic nanoparticles modified for gene delivery: a search for optimum and quantitative criteria.

Authors:  Olga Mykhaylyk; Titus Sobisch; Isabella Almstätter; Yolanda Sanchez-Antequera; Sabine Brandt; Martina Anton; Markus Döblinger; Dietmar Eberbeck; Marcus Settles; Rickmer Braren; Dietmar Lerche; Christian Plank
Journal:  Pharm Res       Date:  2012-01-06       Impact factor: 4.200

3.  Formulation design facilitates magnetic nanoparticle delivery to diseased cells and tissues.

Authors:  Dhirender Singh; JoEllyn M McMillan; Xin-Ming Liu; Hemant M Vishwasrao; Alexander V Kabanov; Marina Sokolsky-Papkov; Howard E Gendelman
Journal:  Nanomedicine (Lond)       Date:  2014-03-19       Impact factor: 5.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.